Founded in 1995, CovalAb has become a leading provider of custom polyclonal and monoclonal antibodies and synthetic peptides to the life sciences research community. Our customers benefit from the experience and dedication of the scientific staff as we aim to provide you with high quality antibodies at competitive prices.

CovalAb in association with The Wellcome Trust Gurdon Institute is organising a one-day conference in Cambridge on 11 July on Post-translational Modifications and Chromatin.
To register and for more information:
http://www.covalab.co.uk/Conference/

Post-translational Modifications & Chromatin A one day conference 11 July 2008 Babbage Lecture Theater, Cambridge, UK

Polyclonals	Monoclonals	Peptides
complete service variety of antigens wide range of hosts	hybridoma development monoclonal production/ purification	different purities and quantities modifications and labels